Category: AI

AI1 Comment

Anthropic and Palantir Partner to Bring Claude AI Models to AWS for U.S. Government Intelligence and Defense Operations

Colin Henderson

November 07, 2024 06:59 AM Eastern Standard Time DENVER–(BUSINESS WIRE)–Anthropic and Palantir Technologies Inc. (NYSE: PLTR) today announced a partnership with Amazon Web Services (AWS) to provide U.S. intelligence and defense agencies access to the Claude 3 and 3.5 family of models on AWS. This partnership allows for an integrated suite of technology to operationalize the use of Claude within Palantir’s AI Platform (AIP) while leveraging the security, agility, flexibility, and sustainability benefits provided by AWS. “We are excited to partner with Anthropic and Palantir and offer new generative AI capabilities that will drive innovation across the public sector. At … Continue reading Anthropic and Palantir Partner to Bring Claude AI Models to AWS for U.S. Government Intelligence and Defense Operations

AI

Europe Must Rethink its Strategy for AI

Colin Henderson

The European Court of Auditors Highlights Urgent Need for Action as Europe Falls Behind in Technological Innovation The ECA stresses that while the European Commission has taken important steps toward developing a strong AI ecosystem, significant challenges remain. Without addressing these key areas, the EU risks falling behind global leaders in AI innovation and missing out on the associated economic and societal benefits. ​By Paolo Licandro​BRUSSELS, November 6, 2024 – 4 MINUTES READ The EU Court of Auditors (ECA) wrote a recommendation on EU strategy on Artificial Intelligence (A.I.). It is evident to everyone that Europe is once again chasing yet another technological revolution … Continue reading Europe Must Rethink its Strategy for AI

AI

Palantir Is Still Full Of Potential (Rating Upgrade)

Colin Henderson

Nov. 06, 2024 1:45 AM ETPalantir Technologies Inc. (PLTR) Stock7 Comments John Bowman 2.58K FollowersPlay (10min) Summary Palantir surprised the market with a 30% YoY revenue growth. I argue that this is not good news, it’s great news. I expect this kind of growth to be sustainable, given what management has shown us is possible. This article covers the Q3 earnings report, and takes a pulse on Palantir. I am issuing an upgrade to strong buy on continued surprise strength, strong treasury, no debt, and continued profitability. hapabapa Introduction I first recommended Palantir Technologies Inc. (NYSE:PLTR) back in June with a … Continue reading Palantir Is Still Full Of Potential (Rating Upgrade)

AI
Colin Henderson

Amazon Keeps Profit Margins in Orbit E-commerce giant’s strong operating earnings offset huge jump in AI spending and counter worries of margin decline By Dan GallagherFollow Nov. 1, 2024 at 6:00 am ET 7 Gift unlocked article Listen (4 min) Amazon CEO Andy Jassy says he expects next year’s capital spending to surpass this year’s planned $75 billion. PHOTO: DAVID RYDER/BLOOMBERG NEWS Like its big tech rivals, Amazon.com AMZN 6.56%increase; green up pointing triangle is spending a king’s ransom on artificial intelligence. Unlike them, it also has plenty of customers dropping money on toothpaste and razorblades.  That strange brew proved a potent mix for the company’s third-quarter reportThursday. Amazon … Continue reading

AI

Nvidia-backed AI firm Iambic unveils drug discovery ‘breakthrough’

Colin Henderson

By Martin Coulter October 29, 20247:08 AM EDTUpdated 7 hours ago LONDON, Oct 29 (Reuters) – Biotech firm Iambic Therapeutics unveiled on Tuesday what it says is a breakthrough artificial intelligence model that could drastically reduce the time and money needed to develop new drugs. A growing number of tech startups are using AI to advance pharmaceutical research. Iambic, which has previously won investment from tech giant Nvidia (NVDA.O), opens new tab, published details of its new AI drug discovery model, named “Enchant”. Enchant was trained on large troves of pre-clinical data, derived from laboratory tests conducted on drugs before they were … Continue reading Nvidia-backed AI firm Iambic unveils drug discovery ‘breakthrough’

AI

The AI National Security Memo and broader evolution of AI inferred

Colin Henderson

AI National Security Memo followed by MicKinsey memo on evolution of AI usage On October 24, 2024, the White House issued the first National Security Memorandum (NSM) on Artificial Intelligence, marking a significant development in U.S. AI policy and national security strategy[1][3]. This memorandum outlines a comprehensive approach to harnessing AI for national security objectives while addressing associated risks and challenges. Key Aspects of the AI National Security Memo AI as a National Security Priority The NSM identifies AI leadership as a critical national security priority for the United States[1]. It acknowledges that competitors have engaged in economic and technological … Continue reading The AI National Security Memo and broader evolution of AI inferred

AI

AI-assisted surgery a ‘game-changer,’ says UHN surgeon

Colin Henderson

Dr. Amin Madani, a surgeon-scientist in UHN’s Sprott Department of Surgery and head of the Surgical AI Research Academy, worked with experts in computer vision to develop technology that applies AI to the surgical field. UHN  A team of researchers at University Health Network (UHN) in Toronto is developing a revolutionary program that harnesses the skills of surgeons by using artificial intelligence to improve the accuracy of surgery in real time. The technology, part of the world-leading research at UHN that is transforming medicine and countless patients’ lives, is set to be used in clinical trials beginning this fall. It … Continue reading AI-assisted surgery a ‘game-changer,’ says UHN surgeon

AI

Arm CEO Sees AI Transforming the World Much Faster Than the Internet

Colin Henderson

Haas, ARM ceo discusses AI progress in a simple fashion Advent of reasoning Importance of cars and medical Broad based growth leaning to exponential based on AI supporting interest development of new improved models ( If you think about the failure rates of drug research — 95% failure, 10 to 12 years to develop a new drug. AI is going to be able to shave those times down, potentially in half. It’s going to be quite, quite dramatic. Growing shortages of data engineers Even with more efficient chips and infrastructure we still needğ hill Arm CEO Sees AI Transforming the World … Continue reading Arm CEO Sees AI Transforming the World Much Faster Than the Internet